MedTech News

3D bioprinted scaffolds enhance bone healing through improved vascularization
Researchers from IBEC led by Oscar Castaño, senior researcher at the Biomaterials for Regenerative Therapies group, developed a novel approach, recently published in Biomaterials Advances.

Innovative red blood cell shape test promises better blood storage and transfusions
Scientists have developed a way of assessing the ability of red blood cells to deliver oxygen by measuring their shape. This test could improve specialist transplant and transfusion practice as well as blood banking. The research is published in eBioMedicine.

Hypersensitive strain sensor enables real-time stroke monitoring
A research team led by Prof. Seung-Kyun Kang from the Department of Materials Science and Engineering at Seoul National University has developed a strain sensor with record-breaking sensitivity in collaboration with researchers from Dankook University, Ajou University, and Purdue University.

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards
TEWKSBURY, Mass., Dec. 20, 2024 /PRNewswire/ — Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure, announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

Onward wins FDA nod for non-invasive spinal cord stim
Onward Medical announced today that it received FDA de novo clearance for its ARC-EX spinal cord stimulation (SCS) system.

FDA Grants IDE Approval for the Pivotal Trial of the JuxtaFlow® Renal Assist Device (RAD)
Roivios Initiates Landmark Study to Demonstrate Safety and Efficacy of an Innovative Renal Assist Device for Cardiac Surgery Patients With Kidney Disease

Vivani Medical initiates first-in-human GLP-1-eluting implant study
Vivani Medical (Nasdaq:VANI) announced today that it initiated screening and enrollment for a first-in-human trial of its GLP-1 implant.

FDA greenlights expansion of BiVacor artificial heart study
BiVacor announced today that it completed the first phase of an FDA early feasibility study (EFS) for its Total Artificial Heart (TAH).